nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—CYP2D6—Sorafenib—liver cancer	0.0852	0.38	CbGbCtD
Hydrocodone—CYP3A4—Sorafenib—liver cancer	0.0542	0.242	CbGbCtD
Hydrocodone—CYP2D6—Doxorubicin—liver cancer	0.0517	0.231	CbGbCtD
Hydrocodone—CYP3A4—Doxorubicin—liver cancer	0.0329	0.147	CbGbCtD
Hydrocodone—Gastrooesophageal reflux disease—Sorafenib—liver cancer	0.0208	0.0332	CcSEcCtD
Hydrocodone—Drug interaction—Sorafenib—liver cancer	0.0203	0.0323	CcSEcCtD
Hydrocodone—Pain in extremity—Sorafenib—liver cancer	0.0137	0.0217	CcSEcCtD
Hydrocodone—Mood swings—Sorafenib—liver cancer	0.0129	0.0206	CcSEcCtD
Hydrocodone—Dehydration—Sorafenib—liver cancer	0.0127	0.0202	CcSEcCtD
Hydrocodone—Hypokalaemia—Sorafenib—liver cancer	0.0124	0.0198	CcSEcCtD
Hydrocodone—Abdominal discomfort—Sorafenib—liver cancer	0.0113	0.018	CcSEcCtD
Hydrocodone—Connective tissue disorder—Sorafenib—liver cancer	0.00929	0.0148	CcSEcCtD
Hydrocodone—Angiopathy—Sorafenib—liver cancer	0.00858	0.0137	CcSEcCtD
Hydrocodone—Mediastinal disorder—Sorafenib—liver cancer	0.00852	0.0136	CcSEcCtD
Hydrocodone—Mental disorder—Sorafenib—liver cancer	0.00828	0.0132	CcSEcCtD
Hydrocodone—Malnutrition—Sorafenib—liver cancer	0.00823	0.0131	CcSEcCtD
Hydrocodone—Muscle spasms—Sorafenib—liver cancer	0.00791	0.0126	CcSEcCtD
Hydrocodone—Cough—Sorafenib—liver cancer	0.00718	0.0114	CcSEcCtD
Hydrocodone—Neck pain—Epirubicin—liver cancer	0.00704	0.0112	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Epirubicin—liver cancer	0.00704	0.0112	CcSEcCtD
Hydrocodone—Myalgia—Sorafenib—liver cancer	0.00701	0.0112	CcSEcCtD
Hydrocodone—Arthralgia—Sorafenib—liver cancer	0.00701	0.0112	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00696	0.0111	CcSEcCtD
Hydrocodone—Dry mouth—Sorafenib—liver cancer	0.00685	0.0109	CcSEcCtD
Hydrocodone—Nervous system disorder—Sorafenib—liver cancer	0.00659	0.0105	CcSEcCtD
Hydrocodone—Thrombocytopenia—Sorafenib—liver cancer	0.00658	0.0105	CcSEcCtD
Hydrocodone—Skin disorder—Sorafenib—liver cancer	0.00652	0.0104	CcSEcCtD
Hydrocodone—Neck pain—Doxorubicin—liver cancer	0.00652	0.0104	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Doxorubicin—liver cancer	0.00652	0.0104	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00612	0.00974	CcSEcCtD
Hydrocodone—Dyspnoea—Sorafenib—liver cancer	0.00599	0.00953	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Sorafenib—liver cancer	0.0058	0.00923	CcSEcCtD
Hydrocodone—Fatigue—Sorafenib—liver cancer	0.00579	0.00922	CcSEcCtD
Hydrocodone—Constipation—Sorafenib—liver cancer	0.00574	0.00914	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Sorafenib—liver cancer	0.00549	0.00874	CcSEcCtD
Hydrocodone—Hot flush—Epirubicin—liver cancer	0.0054	0.00859	CcSEcCtD
Hydrocodone—Menopausal symptoms—Epirubicin—liver cancer	0.00535	0.00852	CcSEcCtD
Hydrocodone—Abdominal pain—Sorafenib—liver cancer	0.00531	0.00845	CcSEcCtD
Hydrocodone—Body temperature increased—Sorafenib—liver cancer	0.00531	0.00845	CcSEcCtD
Hydrocodone—Lethargy—Epirubicin—liver cancer	0.00515	0.0082	CcSEcCtD
Hydrocodone—Pain in extremity—Epirubicin—liver cancer	0.00505	0.00804	CcSEcCtD
Hydrocodone—Osteoarthritis—Epirubicin—liver cancer	0.00505	0.00804	CcSEcCtD
Hydrocodone—Hot flush—Doxorubicin—liver cancer	0.005	0.00795	CcSEcCtD
Hydrocodone—Migraine—Epirubicin—liver cancer	0.00497	0.00791	CcSEcCtD
Hydrocodone—Affect lability—Epirubicin—liver cancer	0.00497	0.00791	CcSEcCtD
Hydrocodone—Menopausal symptoms—Doxorubicin—liver cancer	0.00495	0.00788	CcSEcCtD
Hydrocodone—Hypersensitivity—Sorafenib—liver cancer	0.00495	0.00788	CcSEcCtD
Hydrocodone—Asthenia—Sorafenib—liver cancer	0.00482	0.00767	CcSEcCtD
Hydrocodone—Naloxone—ESR1—liver cancer	0.0048	0.495	CrCbGaD
Hydrocodone—Mood swings—Epirubicin—liver cancer	0.00478	0.00761	CcSEcCtD
Hydrocodone—Lethargy—Doxorubicin—liver cancer	0.00477	0.00759	CcSEcCtD
Hydrocodone—Pruritus—Sorafenib—liver cancer	0.00475	0.00756	CcSEcCtD
Hydrocodone—Dehydration—Epirubicin—liver cancer	0.0047	0.00747	CcSEcCtD
Hydrocodone—Pain in extremity—Doxorubicin—liver cancer	0.00467	0.00744	CcSEcCtD
Hydrocodone—Osteoarthritis—Doxorubicin—liver cancer	0.00467	0.00744	CcSEcCtD
Hydrocodone—Migraine—Doxorubicin—liver cancer	0.0046	0.00732	CcSEcCtD
Hydrocodone—Affect lability—Doxorubicin—liver cancer	0.0046	0.00732	CcSEcCtD
Hydrocodone—Hypokalaemia—Epirubicin—liver cancer	0.0046	0.00731	CcSEcCtD
Hydrocodone—Dizziness—Sorafenib—liver cancer	0.00444	0.00707	CcSEcCtD
Hydrocodone—Mood swings—Doxorubicin—liver cancer	0.00443	0.00704	CcSEcCtD
Hydrocodone—Dehydration—Doxorubicin—liver cancer	0.00435	0.00692	CcSEcCtD
Hydrocodone—Vomiting—Sorafenib—liver cancer	0.00427	0.0068	CcSEcCtD
Hydrocodone—Hypokalaemia—Doxorubicin—liver cancer	0.00425	0.00677	CcSEcCtD
Hydrocodone—Rash—Sorafenib—liver cancer	0.00424	0.00674	CcSEcCtD
Hydrocodone—Dermatitis—Sorafenib—liver cancer	0.00423	0.00673	CcSEcCtD
Hydrocodone—Headache—Sorafenib—liver cancer	0.00421	0.0067	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Epirubicin—liver cancer	0.00406	0.00646	CcSEcCtD
Hydrocodone—Nausea—Sorafenib—liver cancer	0.00399	0.00635	CcSEcCtD
Hydrocodone—Drowsiness—Epirubicin—liver cancer	0.00389	0.00619	CcSEcCtD
Hydrocodone—Urinary tract infection—Epirubicin—liver cancer	0.00378	0.00602	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00375	0.00597	CcSEcCtD
Hydrocodone—Agranulocytosis—Epirubicin—liver cancer	0.00363	0.00578	CcSEcCtD
Hydrocodone—Drowsiness—Doxorubicin—liver cancer	0.0036	0.00573	CcSEcCtD
Hydrocodone—Urinary tract infection—Doxorubicin—liver cancer	0.0035	0.00557	CcSEcCtD
Hydrocodone—Oedema peripheral—Epirubicin—liver cancer	0.00344	0.00548	CcSEcCtD
Hydrocodone—Connective tissue disorder—Epirubicin—liver cancer	0.00343	0.00546	CcSEcCtD
Hydrocodone—Agranulocytosis—Doxorubicin—liver cancer	0.00336	0.00535	CcSEcCtD
Hydrocodone—Oedema peripheral—Doxorubicin—liver cancer	0.00318	0.00507	CcSEcCtD
Hydrocodone—Connective tissue disorder—Doxorubicin—liver cancer	0.00318	0.00506	CcSEcCtD
Hydrocodone—Angiopathy—Epirubicin—liver cancer	0.00317	0.00504	CcSEcCtD
Hydrocodone—Mediastinal disorder—Epirubicin—liver cancer	0.00315	0.00501	CcSEcCtD
Hydrocodone—Mental disorder—Epirubicin—liver cancer	0.00306	0.00487	CcSEcCtD
Hydrocodone—Malnutrition—Epirubicin—liver cancer	0.00304	0.00484	CcSEcCtD
Hydrocodone—Back pain—Epirubicin—liver cancer	0.00294	0.00468	CcSEcCtD
Hydrocodone—Angiopathy—Doxorubicin—liver cancer	0.00293	0.00467	CcSEcCtD
Hydrocodone—Muscle spasms—Epirubicin—liver cancer	0.00292	0.00465	CcSEcCtD
Hydrocodone—Mediastinal disorder—Doxorubicin—liver cancer	0.00291	0.00464	CcSEcCtD
Hydrocodone—Mental disorder—Doxorubicin—liver cancer	0.00283	0.00451	CcSEcCtD
Hydrocodone—Malnutrition—Doxorubicin—liver cancer	0.00281	0.00448	CcSEcCtD
Hydrocodone—Dextromethorphan—CYP2E1—liver cancer	0.00276	0.284	CrCbGaD
Hydrocodone—Back pain—Doxorubicin—liver cancer	0.00272	0.00433	CcSEcCtD
Hydrocodone—Muscle spasms—Doxorubicin—liver cancer	0.00271	0.00431	CcSEcCtD
Hydrocodone—Cough—Epirubicin—liver cancer	0.00265	0.00422	CcSEcCtD
Hydrocodone—Convulsion—Epirubicin—liver cancer	0.00264	0.00419	CcSEcCtD
Hydrocodone—Arthralgia—Epirubicin—liver cancer	0.00259	0.00412	CcSEcCtD
Hydrocodone—Myalgia—Epirubicin—liver cancer	0.00259	0.00412	CcSEcCtD
Hydrocodone—Anxiety—Epirubicin—liver cancer	0.00258	0.00411	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00257	0.00409	CcSEcCtD
Hydrocodone—Dry mouth—Epirubicin—liver cancer	0.00253	0.00403	CcSEcCtD
Hydrocodone—Cough—Doxorubicin—liver cancer	0.00246	0.00391	CcSEcCtD
Hydrocodone—Convulsion—Doxorubicin—liver cancer	0.00244	0.00388	CcSEcCtD
Hydrocodone—Nervous system disorder—Epirubicin—liver cancer	0.00243	0.00387	CcSEcCtD
Hydrocodone—Thrombocytopenia—Epirubicin—liver cancer	0.00243	0.00387	CcSEcCtD
Hydrocodone—Skin disorder—Epirubicin—liver cancer	0.00241	0.00384	CcSEcCtD
Hydrocodone—Hyperhidrosis—Epirubicin—liver cancer	0.0024	0.00382	CcSEcCtD
Hydrocodone—Arthralgia—Doxorubicin—liver cancer	0.0024	0.00381	CcSEcCtD
Hydrocodone—Myalgia—Doxorubicin—liver cancer	0.0024	0.00381	CcSEcCtD
Hydrocodone—Anxiety—Doxorubicin—liver cancer	0.00239	0.0038	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00238	0.00379	CcSEcCtD
Hydrocodone—Dry mouth—Doxorubicin—liver cancer	0.00234	0.00373	CcSEcCtD
Hydrocodone—Hypotension—Epirubicin—liver cancer	0.00232	0.00369	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00226	0.0036	CcSEcCtD
Hydrocodone—Nervous system disorder—Doxorubicin—liver cancer	0.00225	0.00358	CcSEcCtD
Hydrocodone—Thrombocytopenia—Doxorubicin—liver cancer	0.00225	0.00358	CcSEcCtD
Hydrocodone—Insomnia—Epirubicin—liver cancer	0.00225	0.00357	CcSEcCtD
Hydrocodone—Skin disorder—Doxorubicin—liver cancer	0.00223	0.00355	CcSEcCtD
Hydrocodone—Paraesthesia—Epirubicin—liver cancer	0.00223	0.00355	CcSEcCtD
Hydrocodone—Hyperhidrosis—Doxorubicin—liver cancer	0.00222	0.00353	CcSEcCtD
Hydrocodone—Dyspnoea—Epirubicin—liver cancer	0.00221	0.00352	CcSEcCtD
Hydrocodone—Somnolence—Epirubicin—liver cancer	0.00221	0.00351	CcSEcCtD
Hydrocodone—Hypotension—Doxorubicin—liver cancer	0.00215	0.00342	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Epirubicin—liver cancer	0.00214	0.00341	CcSEcCtD
Hydrocodone—Fatigue—Epirubicin—liver cancer	0.00214	0.00341	CcSEcCtD
Hydrocodone—Naloxone—ALB—liver cancer	0.00214	0.22	CrCbGaD
Hydrocodone—Constipation—Epirubicin—liver cancer	0.00212	0.00338	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00209	0.00333	CcSEcCtD
Hydrocodone—Insomnia—Doxorubicin—liver cancer	0.00208	0.00331	CcSEcCtD
Hydrocodone—Paraesthesia—Doxorubicin—liver cancer	0.00206	0.00328	CcSEcCtD
Hydrocodone—Dyspnoea—Doxorubicin—liver cancer	0.00205	0.00326	CcSEcCtD
Hydrocodone—Somnolence—Doxorubicin—liver cancer	0.00204	0.00325	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Epirubicin—liver cancer	0.00203	0.00323	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00198	0.00316	CcSEcCtD
Hydrocodone—Fatigue—Doxorubicin—liver cancer	0.00198	0.00315	CcSEcCtD
Hydrocodone—Constipation—Doxorubicin—liver cancer	0.00196	0.00313	CcSEcCtD
Hydrocodone—Abdominal pain—Epirubicin—liver cancer	0.00196	0.00312	CcSEcCtD
Hydrocodone—Body temperature increased—Epirubicin—liver cancer	0.00196	0.00312	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Doxorubicin—liver cancer	0.00188	0.00299	CcSEcCtD
Hydrocodone—Hypersensitivity—Epirubicin—liver cancer	0.00183	0.00291	CcSEcCtD
Hydrocodone—Body temperature increased—Doxorubicin—liver cancer	0.00182	0.00289	CcSEcCtD
Hydrocodone—Abdominal pain—Doxorubicin—liver cancer	0.00182	0.00289	CcSEcCtD
Hydrocodone—Asthenia—Epirubicin—liver cancer	0.00178	0.00283	CcSEcCtD
Hydrocodone—Pruritus—Epirubicin—liver cancer	0.00176	0.00279	CcSEcCtD
Hydrocodone—Hypersensitivity—Doxorubicin—liver cancer	0.00169	0.00269	CcSEcCtD
Hydrocodone—Asthenia—Doxorubicin—liver cancer	0.00165	0.00262	CcSEcCtD
Hydrocodone—Dizziness—Epirubicin—liver cancer	0.00164	0.00261	CcSEcCtD
Hydrocodone—Pruritus—Doxorubicin—liver cancer	0.00162	0.00259	CcSEcCtD
Hydrocodone—Vomiting—Epirubicin—liver cancer	0.00158	0.00251	CcSEcCtD
Hydrocodone—Rash—Epirubicin—liver cancer	0.00157	0.00249	CcSEcCtD
Hydrocodone—Dermatitis—Epirubicin—liver cancer	0.00156	0.00249	CcSEcCtD
Hydrocodone—Headache—Epirubicin—liver cancer	0.00156	0.00247	CcSEcCtD
Hydrocodone—Dizziness—Doxorubicin—liver cancer	0.00152	0.00242	CcSEcCtD
Hydrocodone—Nausea—Epirubicin—liver cancer	0.00147	0.00235	CcSEcCtD
Hydrocodone—Vomiting—Doxorubicin—liver cancer	0.00146	0.00232	CcSEcCtD
Hydrocodone—Rash—Doxorubicin—liver cancer	0.00145	0.0023	CcSEcCtD
Hydrocodone—Dermatitis—Doxorubicin—liver cancer	0.00145	0.0023	CcSEcCtD
Hydrocodone—Headache—Doxorubicin—liver cancer	0.00144	0.00229	CcSEcCtD
Hydrocodone—Nausea—Doxorubicin—liver cancer	0.00136	0.00217	CcSEcCtD
Hydrocodone—OPRM1—Signaling Pathways—FST—liver cancer	0.000162	0.00118	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PRKCE—liver cancer	0.000159	0.00116	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ADAM17—liver cancer	0.000158	0.00115	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—EPT1—liver cancer	0.000158	0.00114	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TRIO—liver cancer	0.000155	0.00112	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000155	0.00112	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000153	0.00111	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CSF2—liver cancer	0.000152	0.0011	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—TAT—liver cancer	0.00015	0.00109	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—F2—liver cancer	0.000149	0.00108	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PSMA4—liver cancer	0.000149	0.00108	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PSMD10—liver cancer	0.000149	0.00108	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCR4—liver cancer	0.000149	0.00108	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000147	0.00106	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PRKCE—liver cancer	0.000145	0.00105	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000145	0.00105	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PIK3CG—liver cancer	0.000143	0.00104	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CSF2—liver cancer	0.000141	0.00102	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ADAM17—liver cancer	0.000139	0.00101	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—F2—liver cancer	0.000136	0.000984	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—F2—liver cancer	0.000131	0.000951	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PSMD10—liver cancer	0.000131	0.000948	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PSMA4—liver cancer	0.000131	0.000948	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PIK3CG—liver cancer	0.00013	0.000942	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CSF2—liver cancer	0.000128	0.00093	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PIK3CD—liver cancer	0.000126	0.000912	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PIK3CG—liver cancer	0.000125	0.00091	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—F2—liver cancer	0.000119	0.000863	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ADAM17—liver cancer	0.000117	0.000852	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PRKCE—liver cancer	0.000115	0.000838	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PIK3CD—liver cancer	0.000114	0.000828	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CG—liver cancer	0.000114	0.000826	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—F2—liver cancer	0.000111	0.000803	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PSMA4—liver cancer	0.00011	0.000801	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PSMD10—liver cancer	0.00011	0.000801	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PIK3CD—liver cancer	0.00011	0.0008	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—UGDH—liver cancer	0.00011	0.000796	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PIK3CB—liver cancer	0.00011	0.000795	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IGF2—liver cancer	0.000109	0.000794	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CG—liver cancer	0.000106	0.000769	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—EPT1—liver cancer	0.000103	0.000748	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CSF2—liver cancer	0.000102	0.000741	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—RAF1—liver cancer	0.000102	0.000739	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CPT1B—liver cancer	0.000102	0.000738	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GLUL—liver cancer	0.000102	0.000738	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PRKCE—liver cancer	0.000101	0.000735	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—H2AFX—liver cancer	0.000101	0.00073	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—IL2—liver cancer	0.000101	0.00073	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—F2—liver cancer	0.000101	0.00073	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CD—liver cancer	0.0001	0.000726	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PIK3CB—liver cancer	9.95e-05	0.000722	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NR1H4—liver cancer	9.8e-05	0.000711	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TAT—liver cancer	9.78e-05	0.00071	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTA3—liver cancer	9.64e-05	0.000699	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CG—liver cancer	9.62e-05	0.000698	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PIK3CB—liver cancer	9.61e-05	0.000697	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IGF2—liver cancer	9.59e-05	0.000696	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CD—liver cancer	9.31e-05	0.000676	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL2—liver cancer	9.14e-05	0.000663	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TERT—liver cancer	9.1e-05	0.000661	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CSF2—liver cancer	8.96e-05	0.00065	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—RAF1—liver cancer	8.93e-05	0.000648	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—H2AFX—liver cancer	8.83e-05	0.00064	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—IL2—liver cancer	8.82e-05	0.00064	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTA4—liver cancer	8.81e-05	0.00064	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CB—liver cancer	8.72e-05	0.000633	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTA2—liver cancer	8.59e-05	0.000623	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PRKCE—liver cancer	8.56e-05	0.000621	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CD—liver cancer	8.46e-05	0.000614	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KDR—liver cancer	8.33e-05	0.000604	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTA1—liver cancer	8.29e-05	0.000601	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAPK14—liver cancer	8.27e-05	0.0006	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NAT2—liver cancer	8.19e-05	0.000595	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CB—liver cancer	8.12e-05	0.000589	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ESR1—liver cancer	8.11e-05	0.000589	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IGF2—liver cancer	8.11e-05	0.000588	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—F2—liver cancer	8.01e-05	0.000582	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL2—liver cancer	8.01e-05	0.000581	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TERT—liver cancer	7.98e-05	0.000579	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALDOB—liver cancer	7.86e-05	0.00057	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—APC—liver cancer	7.67e-05	0.000557	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CG—liver cancer	7.67e-05	0.000557	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CSF2—liver cancer	7.57e-05	0.000549	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—RAF1—liver cancer	7.55e-05	0.000548	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CRABP1—liver cancer	7.49e-05	0.000544	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—H2AFX—liver cancer	7.46e-05	0.000541	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—IL2—liver cancer	7.46e-05	0.000541	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CB—liver cancer	7.37e-05	0.000535	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KDR—liver cancer	7.3e-05	0.00053	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK14—liver cancer	7.25e-05	0.000526	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—BRAF—liver cancer	7.21e-05	0.000523	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ESR1—liver cancer	7.11e-05	0.000516	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—F2—liver cancer	7.03e-05	0.00051	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL2—liver cancer	6.77e-05	0.000491	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TERT—liver cancer	6.75e-05	0.00049	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CD—liver cancer	6.74e-05	0.000489	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—APC—liver cancer	6.73e-05	0.000488	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CG—liver cancer	6.73e-05	0.000488	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PIK3CA—liver cancer	6.68e-05	0.000485	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SERPINE1—liver cancer	6.67e-05	0.000484	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CPT1B—liver cancer	6.65e-05	0.000482	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GLUL—liver cancer	6.65e-05	0.000482	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—KRAS—liver cancer	6.6e-05	0.000479	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HPGDS—liver cancer	6.55e-05	0.000475	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NR1H4—liver cancer	6.41e-05	0.000465	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—BRAF—liver cancer	6.32e-05	0.000459	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA3—liver cancer	6.3e-05	0.000457	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KDR—liver cancer	6.17e-05	0.000448	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK14—liver cancer	6.13e-05	0.000445	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PIK3CA—liver cancer	6.06e-05	0.00044	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RAF1—liver cancer	6.02e-05	0.000437	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ESR1—liver cancer	6.01e-05	0.000436	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—F2—liver cancer	5.94e-05	0.000431	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CD—liver cancer	5.91e-05	0.000429	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MTOR—liver cancer	5.88e-05	0.000426	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CB—liver cancer	5.88e-05	0.000426	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PIK3CA—liver cancer	5.86e-05	0.000425	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SERPINE1—liver cancer	5.85e-05	0.000424	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PSMD10—liver cancer	5.84e-05	0.000424	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PSMA4—liver cancer	5.84e-05	0.000424	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—KRAS—liver cancer	5.79e-05	0.00042	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA4—liver cancer	5.76e-05	0.000418	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APC—liver cancer	5.68e-05	0.000412	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CG—liver cancer	5.68e-05	0.000412	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GOT2—liver cancer	5.68e-05	0.000412	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA2—liver cancer	5.62e-05	0.000408	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HRAS—liver cancer	5.61e-05	0.000407	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CDKN1B—liver cancer	5.51e-05	0.0004	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—AKT1—liver cancer	5.46e-05	0.000396	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA1—liver cancer	5.42e-05	0.000393	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CASP3—liver cancer	5.41e-05	0.000392	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL2—liver cancer	5.4e-05	0.000392	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6—liver cancer	5.37e-05	0.00039	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NAT2—liver cancer	5.36e-05	0.000389	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—BRAF—liver cancer	5.34e-05	0.000388	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP2E1—liver cancer	5.34e-05	0.000388	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CA—liver cancer	5.32e-05	0.000386	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RAF1—liver cancer	5.28e-05	0.000383	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCND1—liver cancer	5.26e-05	0.000382	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—JUN—liver cancer	5.25e-05	0.000381	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CTNNB1—liver cancer	5.21e-05	0.000378	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CB—liver cancer	5.15e-05	0.000374	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MTOR—liver cancer	5.15e-05	0.000374	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALDOB—liver cancer	5.14e-05	0.000373	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MMP9—liver cancer	5.11e-05	0.000371	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CDKN1A—liver cancer	5.09e-05	0.000369	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CD—liver cancer	5e-05	0.000363	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYCS—liver cancer	5e-05	0.000363	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAPK8—liver cancer	4.97e-05	0.000361	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—AKT1—liver cancer	4.95e-05	0.00036	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CA—liver cancer	4.95e-05	0.000359	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SERPINE1—liver cancer	4.94e-05	0.000359	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HRAS—liver cancer	4.92e-05	0.000357	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GOT1—liver cancer	4.9e-05	0.000356	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GGT1—liver cancer	4.9e-05	0.000356	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CRABP1—liver cancer	4.9e-05	0.000356	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—KRAS—liver cancer	4.89e-05	0.000355	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CDKN1B—liver cancer	4.84e-05	0.000351	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—AKT1—liver cancer	4.78e-05	0.000347	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CASP3—liver cancer	4.74e-05	0.000344	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL2—liver cancer	4.73e-05	0.000343	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6—liver cancer	4.71e-05	0.000342	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCND1—liver cancer	4.61e-05	0.000335	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—JUN—liver cancer	4.6e-05	0.000334	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—VEGFA—liver cancer	4.59e-05	0.000333	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CTNNB1—liver cancer	4.57e-05	0.000332	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—STAT3—liver cancer	4.54e-05	0.00033	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CA—liver cancer	4.49e-05	0.000326	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MMP9—liver cancer	4.48e-05	0.000325	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CDKN1A—liver cancer	4.46e-05	0.000324	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RAF1—liver cancer	4.46e-05	0.000324	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTP1—liver cancer	4.4e-05	0.00032	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK8—liver cancer	4.36e-05	0.000316	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MTOR—liver cancer	4.36e-05	0.000316	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CB—liver cancer	4.36e-05	0.000316	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—AKT1—liver cancer	4.34e-05	0.000315	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HMOX1—liver cancer	4.34e-05	0.000315	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HPGDS—liver cancer	4.28e-05	0.000311	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MYC—liver cancer	4.22e-05	0.000306	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TGFB1—liver cancer	4.21e-05	0.000306	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HRAS—liver cancer	4.16e-05	0.000302	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CDKN1B—liver cancer	4.09e-05	0.000297	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTM1—liver cancer	4.05e-05	0.000294	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AKT1—liver cancer	4.04e-05	0.000293	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—VEGFA—liver cancer	4.02e-05	0.000292	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CASP3—liver cancer	4.01e-05	0.000291	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL2—liver cancer	4e-05	0.00029	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—STAT3—liver cancer	3.98e-05	0.000289	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6—liver cancer	3.98e-05	0.000289	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KRAS—liver cancer	3.9e-05	0.000283	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCND1—liver cancer	3.9e-05	0.000283	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—JUN—liver cancer	3.89e-05	0.000282	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CTNNB1—liver cancer	3.86e-05	0.00028	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP1A1—liver cancer	3.84e-05	0.000278	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PSMD10—liver cancer	3.82e-05	0.000277	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PSMA4—liver cancer	3.82e-05	0.000277	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MMP9—liver cancer	3.79e-05	0.000275	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CDKN1A—liver cancer	3.77e-05	0.000274	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GOT2—liver cancer	3.71e-05	0.000269	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MYC—liver cancer	3.7e-05	0.000269	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TGFB1—liver cancer	3.69e-05	0.000268	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK8—liver cancer	3.68e-05	0.000267	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AKT1—liver cancer	3.67e-05	0.000266	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CA—liver cancer	3.58e-05	0.00026	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MTHFR—liver cancer	3.58e-05	0.00026	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPARA—liver cancer	3.51e-05	0.000255	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP2E1—liver cancer	3.49e-05	0.000253	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TP53—liver cancer	3.47e-05	0.000252	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KRAS—liver cancer	3.42e-05	0.000248	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—VEGFA—liver cancer	3.4e-05	0.000247	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—STAT3—liver cancer	3.37e-05	0.000244	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HRAS—liver cancer	3.31e-05	0.000241	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYCS—liver cancer	3.27e-05	0.000237	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GOT1—liver cancer	3.21e-05	0.000233	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GGT1—liver cancer	3.21e-05	0.000233	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6—liver cancer	3.17e-05	0.00023	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CA—liver cancer	3.14e-05	0.000228	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MYC—liver cancer	3.13e-05	0.000227	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TGFB1—liver cancer	3.12e-05	0.000226	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TP53—liver cancer	3.04e-05	0.000221	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CG—liver cancer	3e-05	0.000218	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AKT1—liver cancer	2.93e-05	0.000212	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HRAS—liver cancer	2.91e-05	0.000211	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPARG—liver cancer	2.9e-05	0.00021	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KRAS—liver cancer	2.89e-05	0.00021	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTP1—liver cancer	2.88e-05	0.000209	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HMOX1—liver cancer	2.84e-05	0.000206	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6—liver cancer	2.78e-05	0.000202	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CA—liver cancer	2.65e-05	0.000193	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTM1—liver cancer	2.65e-05	0.000192	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CD—liver cancer	2.64e-05	0.000192	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALB—liver cancer	2.61e-05	0.000189	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TP53—liver cancer	2.57e-05	0.000186	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKT1—liver cancer	2.57e-05	0.000186	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP1A1—liver cancer	2.51e-05	0.000182	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HRAS—liver cancer	2.46e-05	0.000178	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6—liver cancer	2.35e-05	0.000171	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTHFR—liver cancer	2.34e-05	0.00017	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CB—liver cancer	2.3e-05	0.000167	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPARA—liver cancer	2.29e-05	0.000166	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKT1—liver cancer	2.17e-05	0.000157	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CG—liver cancer	1.96e-05	0.000143	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPARG—liver cancer	1.9e-05	0.000138	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CD—liver cancer	1.73e-05	0.000125	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALB—liver cancer	1.7e-05	0.000124	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CB—liver cancer	1.51e-05	0.000109	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CA—liver cancer	1.4e-05	0.000102	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AKT1—liver cancer	1.15e-05	8.32e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CA—liver cancer	9.18e-06	6.66e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AKT1—liver cancer	7.5e-06	5.44e-05	CbGpPWpGaD
